Literature DB >> 21366407

Outcome and clinical characteristics in pleural empyema: a retrospective study.

Jannie Nielsen1, Christian N Meyer, Signe Rosenlund.   

Abstract

BACKGROUND: Pleural empyema is a serious condition with a considerable mortality rate and morbidity. This study evaluated the correlations between several potential prognostic factors (age, predisposing diseases, early drainage, insufficient initial antimicrobial therapy, thoracic surgical treatment, intrapleural fibrinolysis, and nosocomial status) and outcome.
METHODS: Danish patients with positive pleural cultures attending 3 hospitals over a 9-y period, were identified in the laboratory databases. Clinical details and outcome were evaluated retrospectively by audit of the medical records.
RESULTS: We included 158 patients in this study. The overall mortality was 27% and the median length of stay was 29 days. Mortality correlated independently with several factors: nosocomial infection (odds ratio (OR) 2.62, 95% confidence interval (CI) 1.71-4.16), predisposing conditions (OR 2.17, 95% CI 1.50-3.14), and also with the possibly interventional factors of sufficient initial antimicrobial therapy (OR 0.45, 95% CI 0.31-0.65), thoracic surgery treatment (OR 0.27, 95% CI 0.14-0.52) and local fibrinolytic therapy (OR 0.13, 95% CI 0.06-0.28). Delay in chest tube drainage more than 2 days was not independently correlated with mortality. The initial biochemical diagnostics of non-purulent pleural effusions (63%) did not follow the current international guidelines.
CONCLUSION: Factors correlating independently with survival included the possible interventional parameters of fibrinolytic therapy, insufficient initial antimicrobial therapy, and having thoracic surgery treatment.

Entities:  

Mesh:

Year:  2011        PMID: 21366407     DOI: 10.3109/00365548.2011.562527

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  7 in total

1.  Routine Microbiologic Studies of Pleural Fluid Specimens in Cancer Patients.

Authors:  Marshall Bailey; Georgie Eapen; David Ost; Roberto F Casal; Carlos Jimenez; Saumil Datar; Sofia Molina; Lara Bashoura; Saadia A Faiz; Diwakar D Balachandran; Vickie R Shannon; Ajay Sheshadri; Horiana B Grosu
Journal:  Am J Med       Date:  2019-08-08       Impact factor: 4.965

Review 2.  Infectious pleural effusion status and treatment progress.

Authors:  Wei Yang; Bo Zhang; Ze-Ming Zhang
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

3.  Thoracomyoplasty in the treatment of empyema: current indications, basic principles, and results.

Authors:  Petre Vlah-Horea Botianu; Alexandru Mihail Botianu
Journal:  Pulm Med       Date:  2012-05-14

4.  Pleural infection: a retrospective study of clinical outcome and the correlation to known etiology, co-morbidity and treatment factors.

Authors:  Christian Niels Meyer; Karin Armbruster; Michael Kemp; Trine Rolighed Thomsen; Ram Benny Dessau
Journal:  BMC Pulm Med       Date:  2018-10-12       Impact factor: 3.317

5.  A systematic review of comorbidities and outcomes of adult patients with pleural infection.

Authors:  Tamsin N Cargill; Maged Hassan; John P Corcoran; Elinor Harriss; Rachelle Asciak; Rachel M Mercer; David J McCracken; Eihab O Bedawi; Najib M Rahman
Journal:  Eur Respir J       Date:  2019-10-01       Impact factor: 16.671

6.  Bacteriology, antibiotic resistance and risk stratification of patients with culture-positive, community-acquired pleural infection.

Authors:  Marianthi Iliopoulou; Vasileios Skouras; Zoe Psaroudaki; Magda Makarona; Evangelos Vogiatzakis; Eleni Tsorlini; Eleni Katsifa; Dionisios Spyratos; Dimitra Siopi; Ourania Kotsiou; Stelios Xitsas; Maria Martsoukou; Ioanna Sigala; Ioannis Kalomenidis
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

Review 7.  Recent Insights into the Management of Pleural Infection.

Authors:  Maged Hassan; Shefaly Patel; Ahmed S Sadaka; Eihab O Bedawi; John P Corcoran; José M Porcel
Journal:  Int J Gen Med       Date:  2021-07-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.